Next generation probiotics (NGPs) and human commensal microbes open exciting new possibilities – but they also bring completely new production challenges. How do you grow such demanding organisms at scale, keep them stable, and ensure they survive the journey from lab to end product? In this session, you’ll discover how high throughput screening, niche inspired media, and smarter downstream techniques are transforming the development of NGPs – while also unlocking fresh potential for conventional probiotics and postbiotics.